Gapping up/down: ONON +11%, SSYS +11%, JD +9% and HD +3% after earnings, AMD +4% after upgrade; WMT -6.6% after earnings, WDAY -1.5% after downgrade
Gapping up
In reaction to earnings/guidance:
MVST +14.6%, SE +11.3%, ONON +11.1%, SSYS +10.9%, GAN +10.3%, NU +9.7%, JD +9.1%, TME +7%, DADA +6.9%, IONQ +6.4%, MAG +6.3%, UUUU +5.4%, TTWO +4.9%, UAL +4.5% (sees higher unit revenue outlook for Q2, demand continues to improve), SHLS +4.4%, HUYA +3.8%, RKLB +3.7% (also CAPSTONE spacecraft preps for launch to lunar orbit), FXLV +3.2%, HD +3.2%, DAC +2.9%, CCSI +1.8%, AER +1.3%, VOD +1.1%, RSKD +0.9%
Other news:
COIN +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
HLGN +5% (to restate Full Year 2021 Financials)
FFIE +3.6% (provides update on status of SEC filings)
LOGI +2.8% (increases yearly dividend 10% to CHF 0.96/share)
LH +2.7% (launches at-home collection device for diabetes risk testing)
NETI +2.6% (Scorpio Holdings increases stake by 250K shares)
ABB +2.1% (highlights Energy transition driving profitable growth at Capital Markets Day)
IREN +2% (names new CFO)
FSLR +2% (to sell project development and O&M platform in Japan)
VALE +2% (concludes buyback program and launches new program)
ABT +1.8% (enters into consent decree with FDA related to infant formula plant could restart plant within two weeks; also confirms FY22 EPS guidance)
RH +1.8% (announces $500 mln incremental term debt financing)
IXHL +1.7% (completed a highly constructive pre-IND meeting with the FDA to discuss the development IHL-42X)
LXU +1.4% (authorizes new $50 mln share repurchase program)
EAT +1.2% (CEO Wyman Roberts to retire Kevin Hochman named successor)
WSC +1.2% (acquires Elite Modular Leasing and Sales)
AGCO +1.1% (provides update on ransomware attack)
GILD +1% (FDA lifts hold on IND for lenacapavir for HIV)
UGI +1% (receives funding for RNG projects)
RPAY +1% (authorizes share repurchase program to purchase up to $50 mln of the Company's Class A common stock)
Analyst comments:
PBF +5.6% (upgraded to Neutral from Underweight at JP Morgan)
HEAR +4.9% (upgraded to Outperform from Neutral at Wedbush)
AMD +3.8% (upgraded to Overweight from Neutral at Piper Sandler)
SHAK +2.7% (upgraded to Mkt Perform from Underperform at Raymond James)
TEVA +2.7% (upgraded to Neutral from Underperform at BofA Securities)
EQR +2.2% (upgraded to Buy from Neutral at Mizuho)
Gapping down
In reaction to earnings/guidance:
GLBE -26.7%, BZFD -10.8%, ALLT -9.6%, HPK -8.5%, ALBO -7.6%, WMT -6.6%, RPRX -4.8%
Other news:
IMPL -3.8% (files for $200 mln mixed securities shelf offering)
NLY -3.3% ($100 mln stock offering)
VMEO -2.4% (reports April metrics)
VCYT -2% (new data for Percepta Nasal Swab test in lung cancer risk assessment)
TWTR -2% (has filed its preliminary proxy statement with the U.S. Securities and Exchange Commission in connection with the previously announced agreement for Twitter to be acquired by affiliates of Elon Musk for $54.20 per share in cash; Elon Musk says TWTR deal "cannot move forward" until he gets information on percentage of fake accounts)
ESEA -1.4% (signs contract for construction of additional fuel efficient containerships)
Analyst comments:
NRDY -6.2% (downgraded to Neutral from Buy at Goldman)
MAXR -5.4% (downgraded to Underperform from Neutral at BofA Securities)
WDAY -1.5% (downgraded to Neutral from Buy at UBS)
